← Browse by Condition
Medical Condition

hr positive her2 low breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06340230 Phase 2
Recruiting

SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer

Enrollment
93 pts
Location
China
Sponsor
Shengjing Hospital
View Trial →